GENPLAT 3 mg Injection (Oprelvekin) — Platelet Support After Chemotherapy GENPLAT 3 mg Injection contains oprelvekin, a recombinant human interleukin-11 used to support platelet production in patients undergoing myelosuppressive chemotherapy for non-myeloid malignancies. By stimulating the bone marrow to produce more platelets, GENPLAT helps reduce the severity and duration of chemotherapy-induced thrombocytopenia, which can lower bleeding risk and reduce dependence on platelet transfusions. This biologic therapy is administered under medical supervision, typically in an oncology clinic or hospital, with careful monitoring of blood counts, fluid status, and cardiac function. Available in Pakistan through licensed oncology pharmacies and medical suppliers by prescription, GENPLAT 3 mg plays a vital role in comprehensive supportive cancer care.